Improving health evaluations to capture wider value of therapeutics and incentivise innovation

Bibliographic Details
Main Authors: Mei Sum Chan, Jack C. Kowalik, Tom Ashfield, Jonathan Pearson-Stuttard
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/full
_version_ 1797855050465280000
author Mei Sum Chan
Jack C. Kowalik
Tom Ashfield
Jonathan Pearson-Stuttard
Jonathan Pearson-Stuttard
author_facet Mei Sum Chan
Jack C. Kowalik
Tom Ashfield
Jonathan Pearson-Stuttard
Jonathan Pearson-Stuttard
author_sort Mei Sum Chan
collection DOAJ
first_indexed 2024-04-09T20:16:16Z
format Article
id doaj.art-4677c1e2c2fa429cb2532afe0332c3d6
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-09T20:16:16Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-4677c1e2c2fa429cb2532afe0332c3d62023-03-31T06:52:26ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-03-011110.3389/fpubh.2023.11196521119652Improving health evaluations to capture wider value of therapeutics and incentivise innovationMei Sum Chan0Jack C. Kowalik1Tom Ashfield2Jonathan Pearson-Stuttard3Jonathan Pearson-Stuttard4Health Analytics, Lane Clark & Peacock LLP, London, United KingdomUK Health & Value, Pfizer Ltd., Tadworth, United KingdomUK Medical Affairs - Anti-infectives, Pfizer Ltd., Tadworth, United KingdomHealth Analytics, Lane Clark & Peacock LLP, London, United KingdomDepartment of Epidemiology and Biostatistics, Imperial College London, London, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/fullelements of valueinsurance valueantimicrobial resistancepandemicsvalue assessment
spellingShingle Mei Sum Chan
Jack C. Kowalik
Tom Ashfield
Jonathan Pearson-Stuttard
Jonathan Pearson-Stuttard
Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Frontiers in Public Health
elements of value
insurance value
antimicrobial resistance
pandemics
value assessment
title Improving health evaluations to capture wider value of therapeutics and incentivise innovation
title_full Improving health evaluations to capture wider value of therapeutics and incentivise innovation
title_fullStr Improving health evaluations to capture wider value of therapeutics and incentivise innovation
title_full_unstemmed Improving health evaluations to capture wider value of therapeutics and incentivise innovation
title_short Improving health evaluations to capture wider value of therapeutics and incentivise innovation
title_sort improving health evaluations to capture wider value of therapeutics and incentivise innovation
topic elements of value
insurance value
antimicrobial resistance
pandemics
value assessment
url https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/full
work_keys_str_mv AT meisumchan improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation
AT jackckowalik improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation
AT tomashfield improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation
AT jonathanpearsonstuttard improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation
AT jonathanpearsonstuttard improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation